Evaluation of the hemodialysis-induced changes in plasma glucose and insulin concentrations in diabetic patients: Comparison between the hemodialysis and non-hemodialysis days

Therapeutic Apheresis and Dialysis

Volumn 11, Issue 4, 2007, Pages 288-295

  Abe, Masanori ^a   Kaizu, Kazo ^b   Matsumoto, Koichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Yokohama Social Insurance Central Hospital   (Japan)

Author keywords

Diabetes mellitus; Glucose; Hemodialysis; Hyperglycemia; Immunoreactive insulin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INSULIN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 34547147818     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00492.x     Document Type: Article

References (14)

1. Garber AJ. Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practice. Diabetes Obes Metab 2002 4 : S5 12.
2. Kassab E, McFarlane ST, Sower JR. Vascular complications in diabetes and their prevention. Vasc Med 2001 6 : 249 55.
3. Colwell JA. Vascular thrombosis in type II diabetes mellitus. Diabetes 1993 42 : 8 11.
4. Laakso M. Hyperglycemia and cardiovascular disease in Type 2 diabetes. Diabetes 1999 48 : 937 42.
5. Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993 36 : 1175 84.
6. Kuusisto J, Mykkanen L, Pyorala K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994 43 : 960 7.
7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004 27 : S15 35.
8. Takahashi A, Kubota T, Shibahara N et al. The mechanism of hypoglycemia caused by hemodialysis. Clin Nephrol 2004 62/5 : 362 8.
9. Williams SB, Goldfine AB, Timimi FK, Ting HH. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 1998 97 : 1695 701.
10. Du XL, Fdelstein D, Dimmeler S, Ju Q. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 2001 108 : 1341 8.
11. Ceriello A. Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. Diabetes Nutr Metab 1999 12 : 42 6.
12. Ceriello A. The postprandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev 2000 16 : 125 32.
13. Prato SD. In search of normoglycaemia in diabetes: controlling postprandial glucose. Int J Obes 2002 26 (Suppl 3 9 17.
14. Beisswenger PJ, Szwergold BS, Yeo KT. Glycated proteins in diabetes. Clin Lab Med 2001 21 : 53 78.